USA: Kimberly-Clark to acquire Kenvue

US-based household firm Kimberly-Clark has announced the acquisition of leading global consumer health firm Kenvue for $32 billion.

Kenvue is described as the world’s leading consumer health company by revenue, housing science-backed brands such as Aveeno, Band-Aid, Johnson’s, Listerine, Neutrogena and Tylenol.

Commenting on the move, Kimberly-Clark chairman and chief executive officer Mike Hsu said: “Kenvue is uniquely positioned at the intersection of CPG and healthcare, with exceptional talent and a differentiated brand offering serving attractive consumer health categories. With a shared commitment to developing science and technology to provide extraordinary care, we will serve billions of consumers across every stage of life”.

“Over the last several years, Kimberly-Clark has undertaken a significant transformation to pivot our portfolio to higher-growth, higher-margin businesses while rewiring our organization to work smarter and faster”, he added. “We have built the foundation and this transaction is a powerful next step in our journey”.

Kenvue chief executive officer Kirk Perry said: “Together, our combined strengths, expanded capabilities and resources, and broader reach will empower us to innovate even faster and strengthen our category leadership. We truly believe this transaction with Kimberly-Clark will bring greater value to our shareholders, create new and different potential growth opportunities for our talented employees and deliver even more benefits to our customers and consumers”.

The transaction is expected to close in the second half of 2026, subject to regulatory approvals and other customary closing conditions.

Source: Kimberly-Clark / Kenvue